Document Detail


Radioactive iodine for hyperthyroidism in children and adolescents: referral rate and response to treatment.
MedLine Citation:
PMID:  19250263     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Objectives  Radioactive iodine ((131) I) therapy is increasingly viewed as a safe and effective treatment for paediatric and adolescent hyperthyroidism. Our objective was to estimate treatment response and its predictors and describe current referral practices for (131) I therapy. Design  Retrospective study. Patients  One hundred and thirty-one children 30 days-21 years old with laboratory evidence of hyperthyroidism, seen in an academic paediatric and adolescent endocrinology practice. Measurements  Rate of referral, indications for (131) I, predictors of poor treatment response. Results  Thirty-eight of 102 patients with persistent hyperthyroidism (37%) received (131) I (160 μCi/g thyroid tissue/(131) I uptake), as did an additional 10 patients initially evaluated by adult thyroidologists. Primary indications were intolerance to (29%) or poor control on (19%) antithyroid drugs, patient preference (50%) and unknown (2%). Of 48 patients treated with (131) I, 89% and 11% became hypothyroid after one and two (131) I doses, respectively. The goal of (131) I therapy was attainment of hypothyroidism. 'Poor treatment response' (seen in 27%) was defined as requirement for a second (131) I dose or failure to achieve hypothyroidism after 6 months. Predictors of poor treatment response included: previous use of antithyroid drugs (37%vs. 0%, P = 0·02), ophthalmopathy (58%vs. 8%, P = 0·002), and an interval of ≥12 months from diagnosis to (131) I (50%vs. 10%, P = 0·003). A very elevated free T4 tended to be more prevalent in those with poor response. Conclusions  In children and adolescents with hyperthyroidism, high rates of success after (131) I are achievable. Use of antithyroid drugs, pre-existing eye disease and prolonged time to (131) I may confer relative resistance to (131) I.
Authors:
Shana McCormack; Deborah M Mitchell; Melissa Woo; Lynne L Levitsky; Douglas S Ross; Madhusmita Misra
Related Documents :
6342893 - Thyroid damage--after treatment for hodgkin's disease.
20652073 - Failed switching off in the mibi-parathyroid scintigraphy in a dialyzed patient with se...
20582993 - Initiating levodopa/carbidopa therapy with and without entacapone in early parkinson di...
Publication Detail:
Type:  Journal Article     Date:  2009-02-25
Journal Detail:
Title:  Clinical endocrinology     Volume:  71     ISSN:  1365-2265     ISO Abbreviation:  Clin. Endocrinol. (Oxf)     Publication Date:  2009 Dec 
Date Detail:
Created Date:  2011-01-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0346653     Medline TA:  Clin Endocrinol (Oxf)     Country:  England    
Other Details:
Languages:  eng     Pagination:  884-91     Citation Subset:  IM    
Copyright Information:
© 2009 Blackwell Publishing Ltd.
Affiliation:
Pediatric Endocrine Unit Thyroid Unit, MassGeneral Hospital for Children and Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effect of colorectal cancer upon host peripheral immune cell function.
Next Document:  After bariatric surgery, what vitamins should be measured and what supplements should be given?